185 related articles for article (PubMed ID: 23348906)
41. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
42. Composite Serous Borderline Tumor and Adult Granulosa Cell Tumor-like Area: Is it a True Neoplastic AGCT or Tumor-like Proliferation?
Yu J; Nie X
Int J Gynecol Pathol; 2017 May; 36(3):265-269. PubMed ID: 27648785
[TBL] [Abstract][Full Text] [Related]
43. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract][Full Text] [Related]
44. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children.
Kalfa N; Philibert P; Patte C; Ecochard A; Duvillard P; Baldet P; Jaubert F; Fellous M; Sultan C
Fertil Steril; 2007 Apr; 87(4):896-901. PubMed ID: 17430735
[TBL] [Abstract][Full Text] [Related]
45. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
[TBL] [Abstract][Full Text] [Related]
46. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
47. The C134W (402 C>G) FOXL2 mutation is absent in ovarian gynandroblastoma: insights into the genesis of an unusual tumour.
Oparka R; Cassidy A; Reilly S; Stenhouse A; McCluggage WG; Herrington CS
Histopathology; 2012 Apr; 60(5):838-42. PubMed ID: 22296244
[TBL] [Abstract][Full Text] [Related]
48. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.
Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN
Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948
[TBL] [Abstract][Full Text] [Related]
49. Juvenile Granulosa Cell Tumor with an Unusual Clinical Course: A Late-onset and Late Recurrent Case.
San TH; Ota Y; Fushimi S; Fujisawa M; Yanai H; Toda H; Kunitomo T; Kodama K; Matsukawa A
Acta Med Okayama; 2020 Apr; 74(2):159-163. PubMed ID: 32341591
[TBL] [Abstract][Full Text] [Related]
50. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
[TBL] [Abstract][Full Text] [Related]
51. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
Rosario R; Cohen PA; Shelling AN
Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
[TBL] [Abstract][Full Text] [Related]
52. FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary.
Geiersbach KB; Jarboe EA; Jahromi MS; Baker CL; Paxton CN; Tripp SR; Schiffman JD
Cancer Genet; 2011 Nov; 204(11):596-602. PubMed ID: 22200085
[TBL] [Abstract][Full Text] [Related]
53. Large Ovarian Follicle Cyst: Benign Mimic of Cystic Adult Granulosa Cell Tumor.
McMullen ER; Huang T; Skala SL
Int J Gynecol Pathol; 2022 May; 41(3):289-291. PubMed ID: 34166278
[TBL] [Abstract][Full Text] [Related]
54. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
[TBL] [Abstract][Full Text] [Related]
55. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
[TBL] [Abstract][Full Text] [Related]
56. Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
Guerrieri C; Hudacko R; Anderson P
Int J Gynecol Pathol; 2023 Sep; 42(5):500-507. PubMed ID: 36044294
[TBL] [Abstract][Full Text] [Related]
57. Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation.
Benayoun BA; Anttonen M; L'Hôte D; Bailly-Bechet M; Andersson N; Heikinheimo M; Veitia RA
Oncogene; 2013 May; 32(22):2739-46. PubMed ID: 22797072
[TBL] [Abstract][Full Text] [Related]
58. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
[TBL] [Abstract][Full Text] [Related]
59. Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted
Alexiadis M; Rowley SM; Chu S; Leung DTH; Stewart CJR; Amarasinghe KC; Campbell IG; Fuller PJ
Mol Cancer Res; 2019 Jan; 17(1):177-185. PubMed ID: 30166312
[TBL] [Abstract][Full Text] [Related]
60. FOXL2
Fuller PJ; Nguyen T; Alexiadis M; Chu S
J Pathol; 2022 Jan; 256(1):1-3. PubMed ID: 34687235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
